Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 10

1.

DNA immunization against tissue-restricted antigens enhances tumor immunity after allogeneic hemopoietic stem cell transplantation.

Perales MA, Diab A, Cohen AD, Huggins DW, Guevara-PatiƱo JA, Hubbard VM, Engelhorn ME, Kochman AA, Eng JM, Mortazavi F, Alpdogan O, Terwey TH, Heller G, Wolchok JD, Houghton AN, van den Brink MR.

J Immunol. 2006 Sep 15;177(6):4159-67.

2.
3.

Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.

Theurich S, Fischmann H, Shimabukuro-Vornhagen A, Chemnitz JM, Holtick U, Scheid C, Skoetz N, von Bergwelt-Baildon M.

Cochrane Database Syst Rev. 2012 Sep 12;9:CD009159. doi: 10.1002/14651858.CD009159.pub2. Review.

PMID:
22972135
4.

Reconstructing immunity after allogeneic transplantation.

Giver CR, Li JM, Hossain MS, Lonial S, Waller EK.

Immunol Res. 2004;29(1-3):269-82. Review.

PMID:
15181288
6.

Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.

Talmadge JE.

Int Immunopharmacol. 2003 Aug;3(8):1121-43. Review.

PMID:
12860168
7.

The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success.

Newman RG, Ross DB, Barreras H, Herretes S, Podack ER, Komanduri KV, Perez VL, Levy RB.

Immunol Res. 2013 Dec;57(1-3):125-39. doi: 10.1007/s12026-013-8450-7. Review.

PMID:
24272856
9.

Immunobiology of allogeneic hematopoietic stem cell transplantation.

Welniak LA, Blazar BR, Murphy WJ.

Annu Rev Immunol. 2007;25:139-70. Review.

PMID:
17129175
10.

Acute graft-vs-host disease: pathobiology and management.

Goker H, Haznedaroglu IC, Chao NJ.

Exp Hematol. 2001 Mar;29(3):259-77. Review. Erratum in: Exp Hematol 2001 May;29(5):653.

PMID:
11274753
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk